Cove Street Capital’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1
| Closed | -$5 | – | 101 |
|
|
2024
Q3 | $5 | Sell |
1
-2,824
| -100% | -$14.1K | ﹤0.01% | 99 |
|
|
2024
Q2 | $14K | Sell |
2,825
-1,280,955
| -100% | -$6.35M | 0.01% | 67 |
|
|
2024
Q1 | $6.82M | Buy |
1,283,780
+373,516
| +41% | +$1.98M | 2.16% | 19 |
|
|
2023
Q4 | $5.63M | Sell |
910,264
-195,292
| -18% | -$1.21M | 1.72% | 25 |
|
|
2023
Q3 | $7.47M | Sell |
1,105,556
-513,980
| -32% | -$3.47M | 2.53% | 15 |
|
|
2023
Q2 | $15.7M | Sell |
1,619,536
-264,808
| -14% | -$2.56M | 4.86% | 4 |
|
|
2023
Q1 | $7.11M | Sell |
1,884,344
-61,850
| -3% | -$234K | 2.12% | 17 |
|
|
2022
Q4 | $12.6M | Buy |
1,946,194
+57,700
| +3% | +$374K | 3.44% | 7 |
|
|
2022
Q3 | $16.8M | Sell |
1,888,494
-32,927
| -2% | -$293K | 4.69% | 5 |
|
|
2022
Q2 | $19.2M | Buy |
1,921,421
+49,540
| +3% | +$494K | 4.83% | 4 |
|
|
2022
Q1 | $21.7M | Buy |
1,871,881
+75,517
| +4% | +$874K | 3.83% | 6 |
|
|
2021
Q4 | $19.9M | Sell |
1,796,364
-17,189
| -0.9% | -$191K | 3.49% | 6 |
|
|
2021
Q3 | $16.7M | Buy |
1,813,553
+21,009
| +1% | +$194K | 2.48% | 13 |
|
|
2021
Q2 | $20.2M | Buy |
1,792,544
+113,406
| +7% | +$1.28M | 2.92% | 10 |
|
|
2021
Q1 | $17.8M | Buy |
1,679,138
+559,733
| +50% | +$5.93M | 2.55% | 15 |
|
|
2020
Q4 | $12.1M | Buy |
1,119,405
+459,223
| +70% | +$4.98M | 2.15% | 19 |
|
|
2020
Q3 | $6.42M | Buy |
660,182
+589,942
| +840% | +$5.73M | 1.21% | 30 |
|
|
2020
Q2 | $559K | Buy |
70,240
+30,240
| +76% | +$241K | 0.11% | 59 |
|
|
2020
Q1 | $348K | Buy |
+40,000
| New | +$348K | 0.07% | 76 |
|